All Stories

  1. Safety of ESAs
  2. Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease
  3. Should we really STOP treating patients with IgA nephropathy with steroids?
  4. Current and potential treatment options for hyperphosphatemia
  5. Cost-effectiveness of online hemodiafiltration